Go Pro
LON:EMIS

EMIS Group (EMIS) Share Price, News & Analysis

EMIS Group logo

About EMIS Group Stock (LON:EMIS)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
433,828 shs
Average Volume
675,394 shs
Market Capitalization
£1.23 billion
P/E Ratio
4,085.11
Dividend Yield
2.21%
Price Target
N/A
Consensus Rating
N/A

Company Overview

EMIS Group plc, through its subsidiaries, provides connected healthcare software and systems for healthcare professionals in the United Kingdom. It operates in two segments, EMIS Health and EMIS Enterprise. The EMIS Health segment supplies integrated care technology to national health service markets, including primary, community, acute, and social care. The EMIS Enterprise segment focuses on the B2B technology sector in the healthcare market, such as management of medicines, partner businesses, data and analytics, research and life sciences, and patient-facing services. The company offers clinical software to healthcare organizations under the EMIS brand; patient-centric medical and wellbeing information and digital front door services under the Patient brand name; GP appraisals and training services; and service management solutions to the community pharmacy market under the Pinnacle brand, as well as business intelligence tools for GP practices, federations, and commissioners. It also operates Patient.info, an online health platform that provides personalized online patient-facing services and healthcare content; Patient Access and EMIS Web; and ProScript and ProScript Connect, which enable pharmacies to manage the dispensing process and handle tasks, such as labeling and endorsing, patient records, ordering, and stock control. In addition, the company provides non-clinical ICT solutions, such as bespoke websites for healthcare professionals and other public and private sector organizations; and supplies ICT infrastructure and hosting services. The company was founded in 1987 and is headquartered in Leeds, the United Kingdom. As of October 25, 2023, EMIS Group plc operates as a subsidiary of Optum Health Solutions (UK) Limited.

Receive EMIS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for EMIS Group and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

EMIS Stock News Headlines

Buy this stock tomorrow
Marc Chaikin, founder of Chaikin Analytics, is flagging a little-known company that just secured a partnership with Nvidia - one he believes positions it ahead of Tesla in the autonomous vehicle race. With a market-moving announcement expected on July 31st, Chaikin is urging investors to swap overpriced AI stocks for this under-the-radar name before markets open. He's also releasing a free Hotlist and Hitlist of buy and sell ideas for the second half of 2026.tc pixel
See More Headlines

EMIS Stock Analysis - Frequently Asked Questions

EMIS Group plc (LON:EMIS) issued its earnings results on Wednesday, March, 14th. The company reported $47.20 earnings per share (EPS) for the quarter, topping the consensus estimate of $46.30 by $0.90. The business earned $160.35 million during the quarter. EMIS Group had a trailing twelve-month return on equity of 23.17% and a net margin of 17.23%.

Shares of EMIS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that EMIS Group investors own include RM (RM), Babcock International Group (BAB), The Character Group (CCT), BP (BP), Tullow Oil (TLW) and Vodafone Group Public (VOD).

Company Calendar

Last Earnings
3/14/2018
Today
8/03/2026

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Healthcare Technology
Sub-Industry
Healthcare Technology
Current Symbol
LON:EMIS
CIK
N/A
Fax
N/A
Employees
1,560
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX 0.47
Trailing P/E Ratio
4,085.11
Forward P/E Ratio
N/A
P/E Growth
1.37
Net Income
£30.48 million
Net Margins
17.23%
Pretax Margin
N/A
Return on Equity
23.17%
Return on Assets
7.99%

Debt

Debt-to-Equity Ratio
2.96
Current Ratio
1.07
Quick Ratio
1.83

Sales & Book Value

Annual Sales
£176.86 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
21.90
Book Value
GBX 210 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
64,160,000
Free Float
N/A
Market Cap
£1.23 billion
Optionable
Not Optionable
Beta
-0.13
7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (LON:EMIS) was last updated on 8/3/2026 by MarketBeat.com Staff.
From Our Partners